4.6 Article

CD44 Upregulation in E-Cadherin-Negative Esophageal Cancers Results in Cell Invasion

Journal

PLOS ONE
Volume 6, Issue 11, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0027063

Keywords

-

Funding

  1. American Gastroenterological Association (AGA)/Foundation for Digestive Health and Nutrition (FDHN)
  2. National Institutes of Health [DK075379]
  3. Digestive Disease Research Center [P30-DK058404]
  4. Vanderbilt Ingram Cancer Center [P30-CA068485]

Ask authors/readers for more resources

E-cadherin is frequently lost during epithelial-mesenchymal transition and the progression of epithelial tumorigenesis. We found a marker of epithelial-mesenchymal transition, CD44, upregulated in response to functional loss of E-cadherin in esophageal cell lines and cancer. Loss of E-cadherin expression correlates with increased expression of CD44 standard isoform. Using an organotypic reconstruct model, we show increased CD44 expression in areas of cell invasion is associated with MMP-9 at the leading edge. Moreover, Activin A increases cell invasion through CD44 upregulation after E-cadherin loss. Taken together, our results provide functional evidence of CD44 upregulation in esophageal cancer invasion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available